Malignant tumours following immunosuppressive therapy.

Area of Science:

• Oncology
• Immunology

Background:

• Immunosuppressive therapy is crucial for preventing organ transplant rejection and managing autoimmune diseases.
• A potential link exists between compromised immune surveillance and the development of neoplasms.
• Understanding this relationship is vital for patient management and cancer prevention strategies.

Purpose of the Study:

• To report two distinct cases of malignant disease in patients receiving immunosuppressive therapy.
• To discuss the potential role of immunosuppression in the pathogenesis of these neoplasms.
• To highlight the need for further investigation into the immunosuppression-cancer relationship.

Main Methods:

• Case report analysis of two patients with malignant disease.
• Review of existing literature on immunosuppression and neoplasm development.
• Discussion of pathogenetic mechanisms linking immunosuppression to cancer.

Main Results:

• Case 1: Leiomyosarcoma of the bowel with liver metastasis in an immunosuppressed patient.
• Case 2: Carcinoma in situ of the cervix uteri in an immunosuppressed patient.
• The incidence of neoplasms appears significantly increased in immunologically suppressed individuals.

Conclusions:

• Immunosuppressive therapy may be associated with an increased risk of developing malignant neoplasms.
• Further research is urgently needed to elucidate the precise relationship between immunosuppression and cancer.
• Close monitoring of patients undergoing immunosuppression for early cancer detection is recommended.